medicure pharmacy limited Company Information
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
107 turnbull drive, leicester, LE3 2JW
Website
www.medicare-pharmacy.co.ukmedicure pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICURE PHARMACY LIMITED at £244.8k based on a Turnover of £711.5k and 0.34x industry multiple (adjusted for size and gross margin).
medicure pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICURE PHARMACY LIMITED at £0 based on an EBITDA of £-1.9k and a 4.1x industry multiple (adjusted for size and gross margin).
medicure pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICURE PHARMACY LIMITED at £303.5k based on Net Assets of £145.4k and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medicure Pharmacy Limited Overview
Medicure Pharmacy Limited is a live company located in leicester, LE3 2JW with a Companies House number of 04018200. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in June 2000, it's largest shareholder is z pharm ltd with a 100% stake. Medicure Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £711.5k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medicure Pharmacy Limited Health Check
Pomanda's financial health check has awarded Medicure Pharmacy Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs


1 Strong

5 Regular

6 Weak

Size
annual sales of £711.5k, make it smaller than the average company (£12.6m)
- Medicure Pharmacy Limited
£12.6m - Industry AVG

Growth
3 year (CAGR) sales growth of 8%, show it is growing at a similar rate (7.6%)
- Medicure Pharmacy Limited
7.6% - Industry AVG

Production
with a gross margin of 31.3%, this company has a comparable cost of product (31.3%)
- Medicure Pharmacy Limited
31.3% - Industry AVG

Profitability
an operating margin of -10.5% make it less profitable than the average company (2.5%)
- Medicure Pharmacy Limited
2.5% - Industry AVG

Employees
with 8 employees, this is below the industry average (62)
8 - Medicure Pharmacy Limited
62 - Industry AVG

Pay Structure
on an average salary of £26.6k, the company has an equivalent pay structure (£26.6k)
- Medicure Pharmacy Limited
£26.6k - Industry AVG

Efficiency
resulting in sales per employee of £88.9k, this is less efficient (£148.5k)
- Medicure Pharmacy Limited
£148.5k - Industry AVG

Debtor Days
it gets paid by customers after 31 days, this is near the average (29 days)
- Medicure Pharmacy Limited
29 days - Industry AVG

Creditor Days
its suppliers are paid after 64 days, this is close to average (64 days)
- Medicure Pharmacy Limited
64 days - Industry AVG

Stock Days
it holds stock equivalent to 22 days, this is less than average (32 days)
- Medicure Pharmacy Limited
32 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (13 weeks)
5 weeks - Medicure Pharmacy Limited
13 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 77.7%, this is a higher level of debt than the average (59.1%)
77.7% - Medicure Pharmacy Limited
59.1% - Industry AVG
MEDICURE PHARMACY LIMITED financials

Medicure Pharmacy Limited's latest turnover from March 2024 is estimated at £711.5 thousand and the company has net assets of £145.4 thousand. According to their latest financial statements, Medicure Pharmacy Limited has 8 employees and maintains cash reserves of £24.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 608,972 | ||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 403,510 | ||||||||||||||
Gross Profit | 205,462 | ||||||||||||||
Admin Expenses | 63,156 | ||||||||||||||
Operating Profit | 142,306 | ||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | 13 | ||||||||||||||
Pre-Tax Profit | 142,319 | ||||||||||||||
Tax | -29,355 | ||||||||||||||
Profit After Tax | 112,964 | ||||||||||||||
Dividends Paid | 36,000 | ||||||||||||||
Retained Profit | 76,964 | ||||||||||||||
Employee Costs | 38,855 | ||||||||||||||
Number Of Employees | 8 | 8 | 8 | 8 | 5 | ||||||||||
EBITDA* | 143,209 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 126,895 | 197,729 | 131,459 | 102,457 | 120,510 | 126,586 | 78,421 | 8,489 | 9,987 | 6,652 | 7,826 | 9,207 | 10,538 | 5,117 | 5,403 |
Intangible Assets | 89,743 | 91,940 | 94,137 | 96,334 | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 | |||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | 311,260 | 312,200 | 312,200 | 312,200 | 273,367 | 265,512 | |||||||||
Total Fixed Assets | 527,898 | 601,869 | 537,796 | 510,991 | 120,510 | 126,586 | 78,421 | 56,489 | 331,354 | 320,164 | 55,826 | 57,207 | 58,538 | 53,117 | 53,403 |
Stock & work in progress | 29,569 | 19,569 | 29,569 | 19,569 | 20,606 | 20,795 | 20,849 | 20,992 | 23,924 | 24,713 | 24,301 | 24,599 | |||
Trade Debtors | 62,377 | 66,386 | 64,827 | 52,483 | 411,249 | 428,652 | 483,612 | 370,099 | 90,923 | 137,180 | 388,628 | 377,301 | 410,959 | 110,266 | 334,901 |
Group Debtors | 264,002 | ||||||||||||||
Misc Debtors | 6,232 | 2,705 | 13,625 | 112,530 | 20,885 | ||||||||||
Cash | 24,781 | 66,015 | 53,173 | 68,739 | 15,696 | 24,607 | 15,322 | 15,411 | 25,086 | 20,974 | 4,880 | 5,781 | |||
misc current assets | |||||||||||||||
total current assets | 122,959 | 154,675 | 161,194 | 253,321 | 411,249 | 428,652 | 483,612 | 406,401 | 136,325 | 173,351 | 425,031 | 426,311 | 456,646 | 424,334 | 365,281 |
total assets | 650,857 | 756,544 | 698,990 | 764,312 | 531,759 | 555,238 | 562,033 | 462,890 | 467,679 | 493,515 | 480,857 | 483,518 | 515,184 | 477,451 | 418,684 |
Bank overdraft | 41,708 | 46,527 | 15,846 | 15,846 | |||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 86,890 | 63,119 | 59,861 | 57,785 | 179,017 | 162,046 | 144,895 | 122,330 | 123,315 | 133,023 | 100,000 | 92,017 | 127,291 | ||
Group/Directors Accounts | 19,397 | ||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | 40,044 | 40,044 | |||||||||||||
other current liabilities | 63,539 | 52,283 | 6,172 | 31,686 | 135,387 | 128,514 | |||||||||
total current liabilities | 232,181 | 201,973 | 81,879 | 105,317 | 179,017 | 162,046 | 144,895 | 122,330 | 123,315 | 133,023 | 100,000 | 92,017 | 135,387 | 128,514 | 146,688 |
loans | 163,051 | 171,487 | 236,864 | 250,688 | |||||||||||
hp & lease commitments | 106,699 | 137,860 | |||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 34,757 | 47,833 | 65,975 | ||||||||||||
provisions | 3,550 | 3,550 | 3,550 | 3,550 | 4,176 | 5,171 | 6,084 | 1,697 | 1,997 | 1,268 | 1,489 | 1,749 | 2,065 | 927 | 950 |
total long term liabilities | 273,300 | 312,897 | 240,414 | 254,238 | 38,933 | 53,004 | 72,059 | 1,697 | 1,997 | 1,268 | 1,489 | 1,749 | 2,065 | 927 | 950 |
total liabilities | 505,481 | 514,870 | 322,293 | 359,555 | 217,950 | 215,050 | 216,954 | 124,027 | 125,312 | 134,291 | 101,489 | 93,766 | 137,452 | 129,441 | 147,638 |
net assets | 145,376 | 241,674 | 376,697 | 404,757 | 313,809 | 340,188 | 345,079 | 338,863 | 342,367 | 359,224 | 379,368 | 389,752 | 377,732 | 348,010 | 271,046 |
total shareholders funds | 145,376 | 241,674 | 376,697 | 404,757 | 313,809 | 340,188 | 345,079 | 338,863 | 342,367 | 359,224 | 379,368 | 389,752 | 377,732 | 348,010 | 271,046 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 142,306 | ||||||||||||||
Depreciation | 70,834 | 53,728 | 46,278 | 31,222 | 1,498 | 1,763 | 1,174 | 1,381 | 1,625 | 1,858 | 903 | 955 | |||
Amortisation | 2,197 | 2,197 | 2,197 | 2,197 | |||||||||||
Tax | -29,355 | ||||||||||||||
Stock | 10,000 | -10,000 | 10,000 | 19,569 | -20,606 | -189 | -54 | -143 | -2,932 | -789 | 412 | -298 | 24,599 | ||
Debtors | -1,422 | -9,361 | -86,561 | 65,964 | -17,403 | -54,960 | 113,513 | 5,809 | -38,402 | 14,064 | 11,327 | -33,658 | 15,806 | 60,252 | 334,901 |
Creditors | 23,771 | 3,258 | 2,076 | -121,232 | 16,971 | 17,151 | 22,565 | -985 | -9,708 | 33,023 | 7,983 | 92,017 | -127,291 | 127,291 | |
Accruals and Deferred Income | 11,256 | 46,111 | -25,514 | 31,686 | -135,387 | 6,873 | 128,514 | ||||||||
Deferred Taxes & Provisions | -626 | -995 | -913 | 4,387 | -300 | 729 | -221 | -260 | -316 | 1,138 | -23 | 950 | |||
Cash flow from operations | 55,100 | ||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -19,397 | 19,397 | |||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -8,436 | -65,377 | -13,824 | 250,688 | |||||||||||
Hire Purchase and Lease Commitments | -31,161 | 177,904 | |||||||||||||
other long term liabilities | -34,757 | -13,076 | -18,142 | 65,975 | |||||||||||
share issue | |||||||||||||||
interest | 13 | ||||||||||||||
cash flow from financing | -19,384 | ||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -41,234 | 12,842 | -15,566 | 68,739 | -15,696 | -8,911 | 9,285 | -89 | -9,675 | 4,112 | 16,094 | -901 | 5,781 | ||
overdraft | -4,819 | 30,681 | 15,846 | ||||||||||||
change in cash | -36,415 | -17,839 | -15,566 | 52,893 | -15,696 | -8,911 | 9,285 | -89 | -9,675 | 4,112 | 16,094 | -901 | 5,781 |
medicure pharmacy limited Credit Report and Business Information
Medicure Pharmacy Limited Competitor Analysis

Perform a competitor analysis for medicure pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in LE3 area or any other competitors across 12 key performance metrics.
medicure pharmacy limited Ownership
MEDICURE PHARMACY LIMITED group structure
Medicure Pharmacy Limited has no subsidiary companies.
medicure pharmacy limited directors
Medicure Pharmacy Limited currently has 1 director, Mr Yunus Jussab serving since Oct 2007.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Yunus Jussab | England | 52 years | Oct 2007 | - | Director |
P&L
March 2024turnover
711.5k
+6%
operating profit
-74.9k
0%
gross margin
31.3%
-4.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
145.4k
-0.4%
total assets
650.9k
-0.14%
cash
24.8k
-0.62%
net assets
Total assets minus all liabilities
medicure pharmacy limited company details
company number
04018200
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
June 2000
age
25
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
newell chemist limited (November 2017)
accountant
YP FINANCE
auditor
-
address
107 turnbull drive, leicester, LE3 2JW
Bank
-
Legal Advisor
-
medicure pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to medicure pharmacy limited. Currently there are 5 open charges and 2 have been satisfied in the past.
medicure pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDICURE PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
medicure pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|